October 23, 2015
Authored and Edited by David C. Seastrunk; Daniel F. Klodowski; Elliot C. Cook; Aaron L. Parker
In the 70 Final Written Decisions issued by the Patent Trial and Appeal Board in September, the Board cancelled 869 (93.44%) of the instituted claims and declined to cancel 56 (6.02%) of the instituted claims. A patent owner conceded 5 (0.54%) of the instituted claims by filing a disclaimer.
On a per-case basis, no instituted or substitute claims survived in 62 (88.57%) of the decisions, all instituted claims survived in 4 (5.71%) of the decisions, and a mixed outcome occurred in 4 (5.71%) of the decisions. A mixed outcome occurs where at least one instituted or substitute claim remains patentable, and at least one is cancelled, in a Final Written Decision.
More detailed cumulative statistics on the Board’s IPR and CBM decisions, updated through October 1, 2015, are available here on the AIA Blog.
Numbers of final written decisions by technology center are available here.
Various other PTAB metrics collected and generated by Finnegan are reserved for the use of Finnegan and its clients.
Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.